Determinants of mid- and long-term results in patients after surgical revascularization for ischemic cardiomyopathy

Annals of Thoracic Surgery

Volumn 75, Issue 5, 2003, Pages 1406-1412

  Kleikamp, Georg ^a   Maleszka, Ariane ^a   Reiss, Nils ^a   Stüttgen, Benjamin ^a   Körfer, Reiner ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SURGERY; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDIAL HIBERNATION; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT OUTCOME; DISEASE FREE SURVIVAL; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; CORONARY ARTERY BYPASS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037408097     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04828-2     Document Type: Article

References (25)

1. Bart BA, Shaw LK, McCants CB, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997;30:1002-8.
2. Kron IL, Flanagan TL, Blackbourne LH, et al. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg 1989;210:348-54.
3. Kleikamp G, Posival H, Minami K, et al. Ischemic cardiomyopathy: revascularization vs transplantation. Eur J Cardio-Thorac Surg1997;(Suppl 11):S1-4.
4. Hausmann H, Topp H, Siniawski H, et al. Decision-making in end-stage coronary artery disease: revascularization or heart transplantation? Ann Thorac Surg 1997;64:1296-301.
5. El-Banayosy A, Körfer R, Arusoglu L, et al. Device and patient management in a bridge-to transplant setting. Ann Thorac Surg 2001;71(Suppl):S98-102.
6. Cazeau S, Leclercq C, Lavergne T, et al. Effect of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
7. Alderman E, Fisher L, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
8. Scott SM, Deupree RH, Sharma GV, et al. VA study of unstable angina: 10-year results show duration of surgical advantage for patients with impaired ejection fraction. Circulation 1994;90(5 Pt 2):II120-3.
9. Buxton D. Dysfunction in collateral-dependent myocardium hibernation or repetetive stunning? Circulation 1993;87:1756-8.
10. Eitzman D, al-Aouar Z, Kanter H, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
11. Dreyfus GD, Duboc D, Blasco A, et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg 1994;57:1402-7.
12. Kaul TK, Agnihotri AK, Fields BL, et al. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 1996;111:1001-12.
13. deFilippi CR, Willett DL, Irani WN, et al. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995;92:2863-2868.
14. Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-44.
15. Langenburg SE, Buchanan SA, Blackbourne LH, et al. Predicting survival after coronary revascularization for ischemic cardiomyopathy. Ann Thorac Surg 1995;60:1193-6.
16. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 2002;39:210-8.
17. Depre C, Vanoverschelde JL, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268:H1265-75.
18. Elsasser A, Schlepper M, Klövekorn WP, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2920-31.
19. Schwarz ER, Schöndube FA, Kostin S, et al. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol 1998;31:1018-26.
20. Pagano D, Townend JN, Littler WA, et al. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg 1998;115:791-9.
21. Samady H, Elefteriades JA, Abbott BG, et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999;100:1298-304.
22. Veenhuyzen GD, Singh SN, McAreavey D, et al. Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction. Circulation 2001;104:1489-93.
23. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Circulation 1994;90:2687-2694.
24. Bonchek LI, Burlingame MW, Vazales BE, et al. Applicability of noncardioplegic coronary bypass to high-risk patients: selection of patients, technique, and clinical experience in 3000 patients. J Thorac Cardiovasc Surg 1992;103:230-7.
25. Camici PG, Wijns W, Borgers M, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997;96:3205-14.